WHO ICTRP trial
A randomized controlled study on the efficacy and safety of different doses of…
ITMCTR2025000092 · International Traditional Medicine Clinical Trial Registry (ITMCTR) · Not Recruiting
Key facts
| Trial ID | ITMCTR2025000092 |
|---|---|
| Public title | A randomized controlled study on the efficacy and safety of different doses of Qingrequshi granules compared with traditional decoctions in the treatment of gout |
| Scientific title | A randomized controlled study on the efficacy and safety of different doses of Qingrequshi granules compared with traditional decoctions in the treatment of gout |
| Primary sponsor | Guangdong Provincial Hospital of Chinese Medicine |
| Registry | International Traditional Medicine Clinical Trial Registry (ITMCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Others |
| Countries | China |
| Conditions | Gout |
| Interventions | SLFSN group:SLFSN group: SLFSN+QRQS simulated drug i.e. diclofenac sodium sustained-release tablets (trade name: Voltaren Beijing Novartis Pharmaceuticals Co. Ltd.) 1 tablet each time (75 mg) 1 time a day orally; plus 1 dose of QRQS… |
| Registration date | Jan 13, 2025 |
| Target size | SLFSN group:33;QRQS_K Medium dose group:33;QRQS_K Low dose group:33;QRQS_K High… |
| Registry page | itmctr.ccebtcm.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: